<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rentrad</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник рентгенологии и радиологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of radiology and nuclear medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4676</issn><issn pub-type="epub">2619-0478</issn><publisher><publisher-name>Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20862/0042-4676-2017-98-1-36-43</article-id><article-id custom-type="elpub" pub-id-type="custom">rentrad-195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИКУЮЩЕМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GUIDELINES FOR THE PRACTITIONER</subject></subj-group></article-categories><title-group><article-title>КРИТЕРИИ RECIST 1.1 В ОЦЕНКЕ ОПУХОЛЕЙ ЛЕГКИХ</article-title><trans-title-group xml:lang="en"><trans-title>RECIST 1.1 CRITERIA IN THE ASSESSMENT OF LUNG TUMORS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., заведующая отделением рентгеновской компьютерной и магнитно-резонансной томографии</p><p> </p></bio><bio xml:lang="en"><p>MD, PhD, Head of Department of Computed Tomography and Magnetic Resonance Tomography</p></bio><email xlink:type="simple">cherox-chel@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Важенин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vazhenin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., профессор, чл.-корр. РАН, главный врач</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor, Corresponding Member of Russian Academy of Sciences, Head Physician;</p></bio><email xlink:type="simple">cherox-chel@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фадеева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fadeeva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., заведующая отделением противоопухолевой лекарственной терапии</p></bio><bio xml:lang="en"><p>MD, PhD, Head of Department of Anticancer Drug Therapy</p></bio><email xlink:type="simple">cherox-chel@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шопова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shopova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., врач-рентгенолог</p></bio><bio xml:lang="en"><p>MD, PhD, Radiologist </p></bio><email xlink:type="simple">cherox-chel@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский областной клинический онкологический диспансер» Министерства здравоохранения РФ, ул. Блюхера, 42, Челябинск, 454082, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Oncologic Clynical Dispanser, Ministry of Health of the RF, ul. Blyukhera, 42, Chelyabinsk, 454082, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский областной клинический онкологический диспансер» Министерства здравоохранения РФ,  ул. Блюхера, 42, Челябинск, 454082, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Oncologic Clynical Dispanser, Ministry of Health of the RF, ul. Blyukhera, 42, Chelyabinsk, 454082, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>03</month><year>2017</year></pub-date><volume>98</volume><issue>1</issue><fpage>36</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чернова О.Н., Важенин А.В., Фадеева Н.В., Шопова А.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Чернова О.Н., Важенин А.В., Фадеева Н.В., Шопова А.В.</copyright-holder><copyright-holder xml:lang="en">Chernova O.N., Vazhenin A.V., Fadeeva N.V., Shopova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.russianradiology.ru/jour/article/view/195">https://www.russianradiology.ru/jour/article/view/195</self-uri><abstract><p>В статье рассмотрены основные положения Руководства по применению критериев RECIST версии 1.1. 2009 г. для стандартного подхода к измерению опухолевых очагов в легких и оценке динамики опухолевого процесса в ходе лечения. Содержится перечень условий выполнения мультисрезовой компьютерной томографии (МСКТ), при соблюдении которых методика МСКТ становится максимально воспроизводимой для одного и того же пациента, а оценка динамики заболевания – оптимальной.</p><sec><title> </title><p> </p></sec><sec><title> </title><p> </p></sec></abstract><trans-abstract xml:lang="en"><p>The paper considers the main provisions of the 2009 RECIST guidelines (version 1.1.) criteria for a standard approach to measuring lung tumor lesions and assessing the dynamics of the tumor process during treatment. This paper contains a list of conditions for carrying out multislice spiral computed tomography, under which the latter becomes maximally reproducible for the same patient, as well as an assessment of the course of the disease does optimal.</p><sec><title> </title><p> </p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>компьютерная томография</kwd><kwd>динамика опухоли</kwd><kwd>маркерные очаги</kwd><kwd>стандарты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>computed tomography</kwd><kwd>dynamics of tumor</kwd><kwd>marker pockets</kwd><kwd>standards</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S.,Rubinstein L. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000; 92 (3): 205–16.</mixed-citation><mixed-citation xml:lang="en">Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S.,Rubinstein L. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000; 92 (3): 205–16.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenhauer E.A., Therasse P., Boga-erts J., Schwartz L.H., Sargent D., Ford R. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur.J. Cancer. 2009; 45: 228–47.</mixed-citation><mixed-citation xml:lang="en">Eisenhauer E.A., Therasse P., Boga-erts J., Schwartz L.H., Sargent D., Ford R. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur.J. Cancer. 2009; 45: 228–47.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гележе С.П., Морозов С.П., Мандельблат Ю.Э., Либсон Е.И. Современные критерии лучевой диагностики в оценке эффективности специального противоопухолевого лечения. Российский онкологический журнал. 2004; 3: 39–46. [Gelezhe S.P., Morozov S.P., Mandel’blat Yu.E., Libson E.I. Modern criteria of radiodiagnosis in an efficiency evaluation of special anticancer treatment. Rossiyskiy Onkologicheskiy Zhurnal (Russia Oncological Journal). 2004; 3: 39–46 (in Russ.).]</mixed-citation><mixed-citation xml:lang="en">Гележе С.П., Морозов С.П., Мандельблат Ю.Э., Либсон Е.И. Современные критерии лучевой диагностики в оценке эффективности специального противоопухолевого лечения. Российский онкологический журнал. 2004; 3: 39–46. [Gelezhe S.P., Morozov S.P., Mandel’blat Yu.E., Libson E.I. Modern criteria of radiodiagnosis in an efficiency evaluation of special anticancer treatment. Rossiyskiy Onkologicheskiy Zhurnal (Russia Oncological Journal). 2004; 3: 39–46 (in Russ.).]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 1997; 111 (6): 1718–23.</mixed-citation><mixed-citation xml:lang="en">Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 1997; 111 (6): 1718–23.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forhcoming seventh edition of the TNM classification for lung cancer.J. Thorac. Oncol. 2009; 4 (5): 568–77. Поступила 24.08.2016</mixed-citation><mixed-citation xml:lang="en">Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forhcoming seventh edition of the TNM classification for lung cancer.J. Thorac. Oncol. 2009; 4 (5): 568–77. Поступила 24.08.2016</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
